Date:December 05, 2024
Bio Usawa has a singular focus: to build the manufacturing capacity required to make and supply high quality, effective and affordable antibody-based medicines to the patients who need them. We are applying our 100+ years of combined experience in the industry in close partnership with governments, agencies, educators and health professionals to tap into the talent base for manufacturing these products in Africa, by Africans, for Africans and beyond.
Click here to learn more about our Company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.
Bio Usawa’s Chief Executive Officer, Dr. Menghis, and Chief Operating Officer, Dr. Patrick Lukulay, held a strategic meeting with the Africa CDC’s Local…
August 2025Exciting developments in Anti-VEGF therapy are afoot! Anti-VEGF is the gold standard for managing: • Diabetic Macular Edema (DME) • Wet Age-rela…
August 2025Meet Members of Bio Usawa’s Leadership Team and learn about our Mission to establish end-to-end biologic manufacturing in Africa. Visit our booth for ne…
August 2025